ONC (ONC) Earnings Call Analysis

24/25

Growth 5 Margin 5 Expansion 5 Platform 4 Financial 5

latest quarter score

Earnings Reports

24
B1 Medicines (ONC) Q2 2026: Brukinza Drives 31% Growth, Pipeline Readouts Accelerate Inflection
August 05, 2026
23
ONC Q1 2026: Brukinza Drives 38% Growth, Pipeline Advances Signal Multi-Asset Inflection
May 06, 2026
23
B1 Medicines (ONC) Q4 2025: Brukinza Surges 49% as Global BTK Leadership Expands
February 26, 2026
21
B1 Medicines (ONC) Q3 2025: Brukinza Surges 51% as Global BTK Leadership Reshapes Oncology Portfolio
November 06, 2025
23
B1 Medicines (ONC) Q2 2025: Brukinsa Drives 49% Global Growth as Margin Expands to 87%
August 06, 2025
23
BeiGene (ONC) Q1 2025: 62% Brukinza Growth Drives First GAAP Profitability and Global Expansion
May 07, 2025

Browse all companies